STOCK TITAN

Selectis Health (GBCS) signs $15.7M deal to sell two Georgia skilled nursing facilities

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Selectis Health, Inc. entered into a definitive Purchase and Sale Agreement for two of its skilled nursing facilities in Georgia. Two wholly-owned property subsidiaries agreed to sell substantially all real and personal property related to the 101-bed Glen Eagle Healthcare and Rehab in Abbeville and the 100-bed Eastman Healthcare and Rehab in Eastman for a combined purchase price of $15,700,000, subject to customary prorations, holdbacks, and adjustments. Closing is contingent on completion of due diligence and other conditions, and may not occur.

At the same time, Selectis caused its operating subsidiaries to sign an Operations Transfer Agreement with new affiliated operators. If the sale is completed, this agreement will govern the transfer of the skilled nursing operations at both facilities to the new operators, with consummation of the operations transfer also contingent on closing of the property sale.

Positive

  • None.

Negative

  • None.

Insights

Selectis plans a contingent $15.7M sale of two Georgia skilled nursing facilities with aligned operations transfer.

Selectis Health has signed a Purchase and Sale Agreement to dispose of substantially all real and personal property tied to two Georgia skilled nursing facilities for $15,700,000. The deal covers the 101-bed Glen Eagle Healthcare and Rehab in Abbeville and the 100-bed Eastman Healthcare and Rehab in Eastman.

The company also aligned operations by executing an Operations Transfer Agreement so that, if the real estate sale closes, skilled nursing operations transfer from existing wholly-owned operating subsidiaries to new operators affiliated with the buyers. This keeps property ownership and operating responsibility synchronized across the two facilities.

Both agreements are subject to a Due Diligence Period and multiple customary closing conditions, and the text explicitly notes there is no assurance they will be consummated. Investor impact will depend on whether closing occurs and how divesting these facilities affects future revenue and cash flows, which would be clarified in subsequent company disclosures.

false 0000727346 0000727346 2026-03-05 2026-03-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 5, 2026

 

SELECTIS HEALTH, INC.
(Exact Name of Registrant as Specified in its Charter)

 

Utah   0-15415   87-0340206

(State or other jurisdiction

of incorporation)

 

Commission

File Number

 

(I.R.S. Employer

Identification number)

 

600 17th St., Ste. 2800 South, Denver, CO 80202

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (720) 680-0808

 

(Former name or former address, if changed since last report)

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

ITEM 1.01 ENTRY INTO DEFINITIVE MATERIAL AGREEMENTS

 

Purchase and Sale Agreement

 

Effective on March 5, 2026, Selectis Health, Inc., a Utah corporation (the “Company”) caused two of the Company’s wholly-owned subsidiaries Global Abbeville Property, LLC and Dodge NH, LLC, each a Georgia limited liability company (each a “Seller”) to execute and deliver a definitive Purchase and Sale Agreement (“PSA”) with two newly formed entities: Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC, each a Georgia limited liability company (each a “Purchaser”); pursuant to which each Seller agreed to sell substantially all of the real and personal property owned by each, namely the skilled nursing facilities located at 206 Main Street E, Abbeville, Georgia, upon which is located that certain 101-bed skilled nursing facility commonly known as “Glen Eagle Healthcare and Rehab” (the “Glen Eagle Facility”); and at 556 Chester Highway, Eastman, Georgia, upon which is located that certain 100-bed skilled nursing facility commonly known as “Eastman Healthcare and Rehab” (the “Eastman Facility”, and together with the Glen Eagle Facility, the “Facilities”).

 

The purchase price to be paid by Purchasers for the Facilities is $15,700,000.00, subject to certain prorations, holdbacks and adjustments customary in transactions of this nature.

 

Consummation of the PSA is contingent upon numerous conditions, including, without limitation, satisfactory completion of due diligence during a Due Diligence Period, and other conditions customary in transactions of this nature. There can be no assurance that the PSA will be consummated.

 

Operations Transfer Agreement

 

The Facilities are operated by separate wholly-owned subsidiaries of the Company, namely Global Abbeville, LLC, a Georgia limited liability company, and Global Eastman, LLC, a Georgia limited liability company (collectively, the “Existing Operators”). Concurrently with the execution of the PSA, the Company caused the Existing Operators to execute an Operations Transfer Agreement (“OTA”) with two newly formed entities affiliated with the Purchasers, Abbeville Crossing of Journey LLC and Eastman Trails of Journey LLC, each a Georgia limited liability company (each a “New Operator”). If consummated, of which there can be no assurance, the OTA will govern the transfer of the skilled nursing operations from the Existing Operators to the New Operators.

 

Consummation of the OTA is contingent upon the consummation of the PSA as well as other conditions customary in transactions of this nature.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

10.1   Purchase and Sale Agreement
10.2   Operations Transfer Agreement
104   Cover Page Interactive Data File (embedded with the Inline XBRL document)

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Selectis Health, Inc.

  (Registrant)
   
Dated: March 9, 2026

/s/ Adam Desmond

  Adam Desmond, CEO

 

 

 

 

FAQ

What transaction did Selectis Health (GBCS) enter into on March 5, 2026?

Selectis Health signed a definitive Purchase and Sale Agreement to sell substantially all real and personal property of two Georgia skilled nursing facilities. The deal covers Glen Eagle Healthcare and Rehab and Eastman Healthcare and Rehab, aligning with a separate operations transfer agreement.

What is the purchase price for the two Selectis Health Georgia skilled nursing facilities?

The agreed purchase price is $15,700,000 for the two facilities combined. This amount is subject to customary prorations, holdbacks, and adjustments, which may change the final consideration at closing if the transaction is ultimately consummated.

Which facilities is Selectis Health (GBCS) planning to sell under the Purchase and Sale Agreement?

The transaction covers the 101-bed Glen Eagle Healthcare and Rehab in Abbeville, Georgia, and the 100-bed Eastman Healthcare and Rehab in Eastman, Georgia. These facilities are currently owned through wholly-owned property subsidiaries of Selectis Health.

What is the Operations Transfer Agreement mentioned in the Selectis Health 8-K?

The Operations Transfer Agreement provides for transferring skilled nursing operations at the two Georgia facilities from Selectis Health’s existing operating subsidiaries to new operators affiliated with the buyers. It becomes effective only if the related property Purchase and Sale Agreement is consummated.

Are the Selectis Health facility sale and operations transfer agreements guaranteed to close?

No, closing is not guaranteed. Both the Purchase and Sale Agreement and the Operations Transfer Agreement are contingent on satisfactory due diligence and other customary conditions, and the company explicitly states there can be no assurance the transactions will be consummated.

Who are the buyers of the Selectis Health Georgia skilled nursing facilities?

The buyers are Abbeville Crossing Propco of Journey LLC and Eastman Trails Propco of Journey LLC, both Georgia limited liability companies. New operator entities affiliated with these purchasers will assume skilled nursing operations if the agreements close successfully.

Filing Exhibits & Attachments

5 documents
Selectis Health Inc

OTC:GBCS

View GBCS Stock Overview

GBCS Rankings

GBCS Latest News

GBCS Latest SEC Filings

GBCS Stock Data

6.13M
2.44M
Medical Care Facilities
Healthcare
Link
United States
Greenwood Village